Creating advanced heart tissue using 3D printing technology
A dual 3D bioprinting platform for engineering a thick anisotropic myocardial tissue with geometric vasculature
['FUNDING_R01'] · GEORGE WASHINGTON UNIVERSITY · NIH-11082251
This study is working on a new way to create thick heart tissue using 3D printing, which could help repair hearts damaged by things like heart attacks, making it a hopeful option for those with heart issues.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | GEORGE WASHINGTON UNIVERSITY (nih funded) |
| Locations | 1 site (WASHINGTON, UNITED STATES) |
| Trial ID | NIH-11082251 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a cutting-edge 3D bioprinting platform to engineer thick heart tissue that mimics the natural structure and function of the heart. By utilizing advanced techniques, the project aims to replicate the complex architecture of cardiac tissue, including specialized fibers and blood vessel networks. The approach combines biomaterials and biomechanical stimulation to enhance the growth and functionality of the engineered tissue, potentially offering new solutions for heart repair after damage from conditions like heart attacks.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults with a history of myocardial infarction or other heart-related conditions who are seeking advanced treatment options.
Not a fit: Patients with non-cardiac conditions or those who do not have any history of heart disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative treatments for patients suffering from heart damage, significantly improving recovery and quality of life.
How similar studies have performed: Previous research in tissue engineering has shown promising results in creating functional tissues, suggesting that this innovative approach could also yield significant advancements.
Where this research is happening
WASHINGTON, UNITED STATES
- GEORGE WASHINGTON UNIVERSITY — WASHINGTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ZHANG, LIJIE GRACE — GEORGE WASHINGTON UNIVERSITY
- Study coordinator: ZHANG, LIJIE GRACE
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.